EQUITY RESEARCH MEMO
Scilligence
Generated 5/14/2026
Executive Summary
Conviction (model self-assessment)60/100
Scilligence is a private US-based informatics company founded in 2009 that delivers an integrated software platform to streamline R&D workflows for life sciences organizations. Its core offerings include an Electronic Lab Notebook (ELN), a Registration & Assay Database (RegMol), Materials Inventory System, and Project Management Framework, all enhanced by AI/ML tools. The platform is designed by scientists for scientists, targeting both academic and industrial research teams to improve data management, collaboration, and experimental efficiency. Despite operating in a competitive landscape with players like Benchling and Dotmatics, Scilligence differentiates through its flexible, modular approach and scientific pedigree.
Upcoming Catalysts (preview)
- Q3 2026Release of next-generation AI/ML-enhanced ELN module70% success
- TBDStrategic partnership with a major pharmaceutical company50% success
- TBDExpansion into clinical trial data management40% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)